Global Myasthenia Gravis Treatment Market Size, Competitive Analysis, Share, Forecast- 2020-2026


Posted October 5, 2020 by preeti18

Global myasthenia gravis treatment market is projected to grow at a considerable CAGR of around 7% during the forecast period (2020-2026).
 
Global myasthenia gravis treatment market is projected to grow at a considerable CAGR of around 7% during the forecast period (2020-2026). Increasing awareness related to the rare diseases, approval of promising drugs, the emergence of biologics along with the high adoption of immunotherapies is the key factor contributing towards the growth of the myasthenia gravis (MG) treatment market across the globe. Myasthenia gravis is a chronic autoimmune, neuromuscular disorder that leads to weakness in the skeletal muscles. Eyes, face, and swallowing are the most affected muscles.
Get Free Sample Copy @ https://www.omrglobal.com/request-sample/myasthenia-gravis-treatment-market
In May 2019, the American Academy of Neurology had approved Eculizumab (Soliris), a particularly high-cost biologic that treats rare and ultra-rare diseases to make treatment of myasthenia gravis patients. Therefore, the emergence of new biologics is expected to drive the growth of the global myasthenia market. Ongoing R&D by government or non-government institutions to find new ways to treat autoimmune disorders is anticipated to offer considerable opportunities to the growth of the global market. However, the high cost of treatment is anticipated to hinder the growth of the myasthenia gravis treatment market across the globe.
Browse for Full Report [email protected] https://www.omrglobal.com/industry-reports/myasthenia-gravis-treatment-market
Market Segmentation
Global Myasthenia Gravis Treatment Market by Treatment
Medication
• Cholinesterase Inhibitors
• Corticosteroids
• Immunosuppressants
• Surgery
• Others
Global Myasthenia Gravis Treatment Market by End-User
• Hospitals
• Clinics
• Other
Regional Analysis
North America
• US
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• Rest of Asia-Pacific
Rest of the World
Company Profiles
• AbbVie, Inc.
• Alexion Pharmaceutical, Inc.
• Amneal Pharmaceuticals, Inc.
• Argenx SE
• Astellas Pharma, Inc.
• Avadel Pharmaceuticals PLC
• Bausch Health Companies Inc.
• Baxter International, Inc.
• CSL Behring
• CuraVac, Inc.
• F. Hoffmann-La Roche, Ltd.
• GlaxoSmithKline plc
• Grifols SA
• Immunovant, Inc.
• Mitsubishi Tanabe Pharma Corp.
• Novartis AG
• RA Pharmaceuticals, Inc.
• Takeda Pharmaceutical Co., Ltd.
• UCB Pharma
• Valeant Pharmaceuticals International, Inc.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/myasthenia-gravis-treatment-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404
-- END ---
Contact Email [email protected]
Issued By preeti
Country India
Categories Business
Tags Global Myasthenia Gravis Treatment Market
Last Updated October 5, 2020